Skip to main content

Table 3 Five-year disease-free survival for stage III breast cancer

From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen

  Chemotherapy + Placebo Chemotherapy + Panagen [25]
Patients Survived patients % Patients Survived patients % Survival, %
IIIA 2 1   50 7 4   57 47
IIIB 6 1 17 17 12 5 42 50
IIIC 0 - - 6 4 67  
Stage III, total 8 2   25 25 13   52